Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.
Lifestyle Modifications
Cardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to the heart muscle and exacerbate symptoms.
Pharmacological Treatments
Pharmacological treatments play a significant role in alleviating symptoms and preventing disease progression. Common medications include ACE inhibitors like lisinopril, beta-blockers like metoprolol, and diuretics like furosemide. In cases of heart failure, aldosterone antagonists are commonly used, and digoxin may be considered for specific indications, such as atrial fibrillation or refractory symptoms. Arrhythmia control might involve antiarrhythmic medications and implanted devices like ICDs. Fluid intake should be limited to 2 liters daily if congestion signs are present.
Specific Conditions
Avoiding dehydration is essential for patients with hypertrophic cardiomyopathy (HCM). Beta-blockers may be necessary to maintain cardiac output and reduce the risk of left ventricular outflow tract obstruction during systole. Patients with dilated cardiomyopathy (DCM) may benefit from biventricular pacing, also called cardiac resynchronization therapy (CRT), which can increase the ejection fraction and reverse some structural changes in the myocardium.
Advanced Therapies
Surgical management may be considered in more severe cases when other treatments are ineffective.
Septal Myectomy
Septal myectomy is a standard procedure for patients with hypertrophic obstructive cardiomyopathy (HOCM). This open-heart surgery removes a portion of the thickened septal wall that obstructs blood flow, thereby reducing symptoms and improving exercise capacity.
Mitral Valve Surgery
Another essential surgical option is mitral valve surgery, which includes repair or replacement. This procedure addresses secondary mitral regurgitation due to dilated cardiomyopathy, alleviating heart failure symptoms and potentially improving survival.
Left Ventricular Assist Device (LVAD)
LVAD implantation is a vital option for patients with end-stage heart failure due to dilated or ischemic cardiomyopathy. LVADs are mechanical pumps that assist the left ventricle in pumping blood. They serve as a bridge to heart transplantation or as long-term therapy for patients ineligible for heart transplantation, significantly improving quality of life and survival.
Cardiac Transplantation
Cardiac transplantation is recommended for patients with end-stage heart failure who are unresponsive to other treatments. It involves surgically replacing a patient's failing heart with a healthy donor heart.
Alcohol Septal Ablation
This procedure is a less invasive alternative to septal myectomy for hypertrophic cardiomyopathy patients who are not suited for open-heart surgery. It involves injecting alcohol into a small branch of the coronary artery to induce controlled infarction and septal thinning, reducing symptoms and outflow tract obstruction. However, it may have higher recurrence rates compared to septal myectomy.
Implantable Cardioverter-Defibrillator (ICD)
Lastly, the Implantable Cardioverter-Defibrillator (ICD) monitors and corrects life-threatening arrhythmias, significantly reducing the risk of sudden cardiac death and improving overall survival.
Monitoring and Follow-up
Regular follow-ups and monitoring are crucial for patients with cardiomyopathy to adjust treatment plans as necessary. Patient education is also vital in managing the condition, ensuring patients understand their disease and the importance of adhering to treatment plans.
Medical management of cardiomyopathy includes lifestyle modifications such as following a low-salt diet, exercising as tolerated, and avoiding alcohol and tobacco to prevent further cardiac damage.
Treatments often involve ACE inhibitors to reduce afterload, beta-blockers, and aldosterone antagonists to control neurohormonal activity, and diuretics to reduce preload and alleviate symptoms.
Anticoagulants are used if there is a risk of blood clots, and dysrhythmias are treated with appropriate antiarrhythmics.
Severe cases require surgical interventions.
For example, severe hypertrophic cardiomyopathy may require a septal myectomy to remove a portion of the thickened septal wall that obstructs blood flow.
Alternatively, alcohol septal ablation, suitable for those unsuited for open-heart surgery, involves injecting alcohol into a coronary artery to induce controlled infarction and septal thinning.
For dilated cardiomyopathy, mitral valve repair or replacement is recommended to address secondary mitral regurgitation.
Lastly, end-stage heart failure from dilated cardiomyopathy may require ventricular assist device implantation or cardiac transplantation.
繁體中文
